| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/07/2011 | CN101613734B Method for preparing plasma polypeptide |
| 09/07/2011 | CN101457249B Method for preparing indissoluble aquatic collagen protein source ACE inhibitor peptides |
| 09/07/2011 | CN101058805B Method of producing mutation procarboxypeptidase B and mutation carboxypeptidase B |
| 09/06/2011 | US8013210 for large scale biosynthesis of therapeutically important proteins |
| 09/06/2011 | US8013140 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
| 09/06/2011 | US8013139 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
| 09/06/2011 | US8013128 Antibodies and related molecules that bind to PSCA proteins |
| 09/06/2011 | US8013127 Antibody that binds to ER-α36 |
| 09/06/2011 | US8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer |
| 09/06/2011 | US8013125 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8012931 Modified FGF-21 polypeptides and their uses |
| 09/06/2011 | US8012928 Truncated PAP2 and methods of making and using same |
| 09/06/2011 | US8012754 Antibody compositions |
| 09/06/2011 | US8012748 Peripheral nervous system specific sodium channel nucleic acids |
| 09/06/2011 | US8012739 Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase pairs |
| 09/06/2011 | US8012734 Cellulase variants with reduced inhibition by glucose |
| 09/06/2011 | US8012731 Phosphodiesterase and gene thereof |
| 09/06/2011 | US8012729 Mutant glucose dehydrogenase |
| 09/06/2011 | US8012716 Animal protein-free medium; making and purifying botulinum toxin |
| 09/06/2011 | US8012715 Methods for production of proteins |
| 09/06/2011 | US8012714 Sequence diversity generation in immunoglobulins |
| 09/06/2011 | US8012713 Enzyme production in culture medium comprising raw glycerol |
| 09/06/2011 | US8012712 Cell-free system for synthesis of proteins derived from cultured mammalian cells |
| 09/06/2011 | US8012704 Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use |
| 09/06/2011 | US8012697 Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma |
| 09/06/2011 | US8012484 Using immunoglobulins which inhibit natural killer cell activity as therapeutic agents in prevention and treatment of ischemic injury; antitumor agents; adenosine receptor agonist |
| 09/06/2011 | US8012482 Humanized anti-TGF-beta antibodies |
| 09/06/2011 | US8012479 Recombinant toxin fragments |
| 09/06/2011 | US8012476 Molecules with extended half-lives, compositions and uses thereof |
| 09/06/2011 | US8012475 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
| 09/06/2011 | US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders |
| 09/06/2011 | CA2452260C Novel variants and exons of the glyt1 transporter |
| 09/01/2011 | WO2011105841A2 Recombinant expression vector for expressing brazzein, and novel multiple mutation brazzein variant having greater sweetness |
| 09/01/2011 | WO2011105544A1 Tumor marker, antibody to same, detection kit for same, and method for detecting same |
| 09/01/2011 | WO2011105424A1 Dendritic cell immunoreceptor stimulant |
| 09/01/2011 | WO2011034406A3 Rhodanobacter ginsenosidimutans kctc22231t-derived ginsenoside glycosidase, and use thereof |
| 09/01/2011 | WO2011003600A8 METHOD FOR THE PURIFICATION OF INTERFERON-β |
| 09/01/2011 | US20110213132 Production of ngf in plant |
| 09/01/2011 | US20110213128 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 09/01/2011 | US20110212894 Decellularization method for scaffoldless tissue engineered articular cartilage or native cartilage tissue |
| 09/01/2011 | US20110212489 Culture medium for eukaryotic cells |
| 09/01/2011 | US20110212488 Immortalized avian cell lines and use thereof |
| 09/01/2011 | US20110212448 Gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof |
| 09/01/2011 | US20110212128 Universal virus-like particle (VLP) influenza vaccines |
| 09/01/2011 | US20110212109 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212084 Binding members for ige molecules |
| 09/01/2011 | CA2788992A1 Method for increasing n-glycosylation site occupancy on therapeutic glycoproteins produced in pichia pastoris |
| 08/31/2011 | EP2362221A1 Antagonists of HMG1 for treating inflamatory conditions |
| 08/31/2011 | EP2361982A1 Human gene encoding ubiquitin conjugating enzyme |
| 08/31/2011 | EP2361981A1 RNA sequence-specific mediators of RNA interference |
| 08/31/2011 | EP2361966A1 Mesoderm and definitive endoderm cell populations |
| 08/31/2011 | EP2361932A1 Immunoglobulin chimeric monomer-dimer hybrids |
| 08/31/2011 | EP1694703B1 Process for purifying interferon beta |
| 08/31/2011 | EP1446422B1 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 08/31/2011 | EP1402015B1 A soluble complex comprising a retroviral surface glycoprotein and fkpa or slyd |
| 08/31/2011 | EP1334185B1 Method for producing proteins by electroporation |
| 08/31/2011 | EP1095140B1 Neurotrophic factors |
| 08/31/2011 | CN102171362A Process for the production of the actinobacillus pleuropneumoniae toxins APXI or APCIII in a liquid culture medium under supply of air enriched in carbon dioxide |
| 08/31/2011 | CN102171361A Process for the production of the actinobacillus pleuropneumonias toxin ApxI employing a culture medium comprising calcium-borogluconate complex |
| 08/31/2011 | CN102171360A Small scale shaker flask cultivation |
| 08/31/2011 | CN102171337A Enhanced animal cell growth using ultrasound |
| 08/31/2011 | CN102171336A Ultrasound enhanced growth of microorganisms |
| 08/31/2011 | CN102171334A Method for producing purified influenza virus antigen |
| 08/31/2011 | CN102170907A Pharmaceutical composition for treatment and prevention of cancer |
| 08/31/2011 | CN102168124A Method for preparing wheat germ active polypeptide by composite enzyme and alkaline combination method |
| 08/31/2011 | CN102168057A Engineering bacteria expressing active peptides and method of preparing mixed polypeptide |
| 08/31/2011 | CN102168053A Paenibacilluspolymyxa strain for coproduction of LI-F type antibiotic and dibutyl phthalate and application thereof |
| 08/31/2011 | CN102167732A Protein type algicidal compound and preparation method thereof |
| 08/31/2011 | CN102166200A Freeze-drying composition containing cerebroprotein hydrolysates and preparation method of freeze-drying composition |
| 08/31/2011 | CN101701239B Method for preparing glutathione using hydantoinase |
| 08/31/2011 | CN101624613B Bio-modification preparation method for improving activity of laver phycoerythrin |
| 08/31/2011 | CN101597578B Enramycin producing strain and extraction method by using macroporous resin |
| 08/31/2011 | CN101591691B High density fermentation culture medium of restructured human interferon alpha2b |
| 08/31/2011 | CN101413019B Preparation of casein glycomacmpepride |
| 08/31/2011 | CN101348821B High purity sericin powder prepared from silkworm cocoon blaze and preparation thereof |
| 08/31/2011 | CN101343309B Method for simultaneously separating soy protein and oil fat with inverse micelle abstraction technique |
| 08/30/2011 | US8008547 Glyphosate-N-acetyltransferase (GAT) genes |
| 08/30/2011 | US8008461 Carbonyl reductase, gene therefor and use thereof |
| 08/30/2011 | US8008451 Antibodies to TNF (tumor necrosis factor) receptor family members |
| 08/30/2011 | US8008447 Crystallization of antibody or fragment thereof |
| 08/30/2011 | US8008446 Auto-antibodies against the melanocortin-4 receptor |
| 08/30/2011 | US8008445 Metalloproteinase 9 binding proteins |
| 08/30/2011 | US8008443 Modulation of antibody effector function by hinge domain engineering |
| 08/30/2011 | US8008431 Tumor-associated peptides that bind to MHC-molecules |
| 08/30/2011 | US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 08/30/2011 | US8008248 Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 08/30/2011 | US8008076 Method of producing a nucleic acid encoding an antibody |
| 08/30/2011 | US8008073 Anti-Mpl antibodies |
| 08/30/2011 | US8008058 Ketose 3-epimerase, its preparation and uses |
| 08/30/2011 | US8008056 Variant Hypocrea jecorina CBH2 cellulases |
| 08/30/2011 | US8008054 Thermostable nucleic acid polymerase from Thermococcus gorgonarius |
| 08/30/2011 | US8008052 Process for producing glycolic acid from formaldehyde and hydrogen cyanide |
| 08/30/2011 | US8008048 L-cysteine-producing bacterium and a method for producing L-cysteine |
| 08/30/2011 | US8008044 Biosynthesis of botulinium toxins by anaerobic fermentation of Clostridium botulin toxins |
| 08/30/2011 | US8008043 Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom |
| 08/30/2011 | US8008042 Aspergillus niger promoter for expressing genes in host cells |
| 08/30/2011 | US8008041 Site directed mutagenesis; orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases; cells |
| 08/30/2011 | US8008027 Methods of screening for compounds that modulate the activity of ADEC, a chemokine expressed in inflamed adenoid |